2660 results
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
Paralytic Agents ... (Depolarizing Agent ... vasopressors #paralytics #agents
Clinical Pharmacologic Properties of Antiarrhythmic Drugs

#Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Pharmacologic Properties
Antiarrhythmic Medications - Vaughan Williams Classification - Summary Table
Class I agents - Sodium Channel Blockersâ €
Class II
Table Class I agents ... Blockersâ € Class II agents ... Anti-sympathetic agents ... Most agents in this ... Blockers Class IV agents
Causes of Myocarditis
Infectious Etiologies:
 • Viral agents: Adenoviruses, Enteroviruses (coxsackievirus), Herpesviruses (human herpesvirus 6, Epstein—Barr virus),
Etiologies: • Viral agents ... B19 • Parasitic agents ... pallidum • Fungal agents ... species • Protozoal agents ... #Myocarditis #differential
Vasopressors Table 
Rough properties by Target Receptor, Heart Rate/Inotropy, Systemic Vascular Resistance, Cardiac Output, Blood Pressure,
Table Rough properties ... #Vasopressors #Properties
Differential Diagnosis for Hemolytic Anemia
Intrinsic Causes:
 • Enzyme deficiencies ex. G6PD, pyruvate kinase 
 • Hemoglobinopathies
Differential Diagnosis ... Malaria • Oxygen agents ... nitrates • Other agents ... Hemolytic #Anemia #Differential
Antifungal Coverage Activity Antibiogram 

Spectrum of action of systemic antifungal agents. Solid blocks represent species in
systemic antifungal agents ... the antifungal agent
Nerve agent exposure is a generalized whole-body exposure. Similar to organophosphates, symptoms and signs result from
Nerve agent exposure ... organophosphates, nerve agents
Summary of Non-Insulin Agents Used to Treat Diabetes

#Diabetes #Pharmacology #Comparison #Table #Medications #Noninsulin #Orals #Agents
of Non-Insulin Agents ... Noninsulin #Orals #Agents
Indications for and pharmacological properties of approved SGLT2 inhibitors

Canagliflozin - Dapagliflozin - Empagliflozin - Ertugliflozin

#SGLT2 #Inhibitors
pharmacological properties